TLR9-independent activation of B lymphocytes by bacterial DNA

DNA and Cell Biology

Volumn 25, Issue 5, 2006, Pages 253-261

  Cortez Gonzalez, Xochitl ^a,b   Pellicciotta, Ilenia ^a   Gerloni, Mara ^a,d   Wheeler, Matthew C ^a,b   Castiglioni, Paola ^a   Lenert, Petar ^c   Zanetti, Maurizio ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; CD4 ANTIGEN; CD8 ANTIGEN; CHLOROQUINE; PLASMID DNA; THYMIDINE; TOLL LIKE RECEPTOR 9; TRITIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CPG ISLAND; GENE EXPRESSION; HUMAN; IMMUNIZATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; TRANSGENE;

ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; DNA PRIMERS; DNA, BACTERIAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TOLL-LIKE RECEPTOR 9; TRANSGENES; UP-REGULATION;

BACTERIA (MICROORGANISMS); MAMMALIA;

EID: 33744804308     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2006.25.253     Document Type: Article

References (54)

1. ADEREM, A. (2002). How to eat something bigger than your head. Cell 110, 5-8.
2. AHMAD-NEJAD, P., HACKER, H., RUTZ, M., BAUER, S., VABULAS, R.M., and WAGNER, H. (2002). Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur. J. Immunol. 32, 1958-1968.
3. AKIRA, S., and TAKEDA, K. (2004). Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499-511.
4. BASNER-TSCHAKARJAN, E., MIRMOHAMMADSADEGH, A., BAER, A., and HENGGE, U.R. (2004). Uptake and trafficking of DNA in keratinocytes: Evidence for DNA-binding proteins. Gene Ther. 11, 765-774.
5. BAUER, M., REDECKE, V., ELLWART, J.W., SCHERER, B., KREMER, J.P., WAGNER, H., and LIPFORD, G.B. (2001a). Bacterial CpG-DNA triggers activation and maturation of human CD11c-, CD123+ dendritic cells. J. Immunol. 166, 5000-5007.
6. BAUER, S., KIRSCHNlNG, C.J., HACKER, H., REDECKE, V., HAUSMANN, S., AKIRA, S., WAGNER, H., and LIPFORD, G.B. (2001b). Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl. Acad. Sci. USA 98, 9237-9242.
7. BOULE, M.W., BROUGHTON, C., MACKAY, F., AKIRA, S., MARSHAK-ROTHSTEIN, A., and RIFKIN, I.R. (2004). Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J. Exp. Med. 199, 1631-1640.
8. CASTIGLIONI, P., LU, C., LO, D., CROFT, M., LANGLADE-DEMOYEN, P., ZANETTI, M., and GERLONI, M. (2003). CD4 T cell priming in dendritic cell-deficient mice. Int. Immunol. 15, 127-136.
9. CASTIGLIONI, P., GERLONI, M., and ZANETTI, M. (2004). Genetically programmed B lymphocytes are highly efficient in inducing anti-virus protective immunity by central memory CD8 T cells. Vaccine 23, 699-708.
10. CHUANG, T.H., LEE, J., KLINE, L., MATHISON, J.C., and ULEVITCH, R.J. (2002). Toll-like receptor 9 mediates CpG-DNA signaling. J. Leukoc. Biol. 71, 538-544.
11. CORNELIE, S., HOEBEKE, J., SCHACHT, A.M., BERTIN, B., VIGOGNE, J., CAPRON, M., and RIVEAU, G. (2004). Direct evidence that toll-like receptor 9 (TLR9) functionally binds plasmid DNA by specific cytosine-phosphate-guanine motif recognition. J. Biol. Chem. 279, 15124-15129.
12. FILACI, G., CONTINI, P., GRASSO, I., BIGNARDI, D., GHIO, M., LANZA, L., SCUDELETTI, M., PUPPO, F., BOLOGNESI, M., ACCOLLA, R.S., et al. (1998). Double-stranded deoxyribonucleic acid binds to HLA class II molecules and inhibits HLA class II-mediated antigen presentation. Eur. J. Immunol. 28, 3968-3979.
13. FILACI, G., GERLONI, M., RIZZI, M., CASTIGLIONI, P., CHANG, H.D., WHEELER, M.C., FIOCCA, R., and ZANETTI, M. (2004). Spontaneous transgenesis of human B lymphocytes. Gene Ther. 11, 42-51.
14. GERLONI, M., RIZZI, M., CASTIGLIONI, P., and ZANETTI, M. (2004). T cell immunity using transgenic B lymphocytes. Proc. Natl. Acad. Sci. USA 101, 3892-3897.
15. GLOVER, D.J., LIPPS, H.J., and JANS, D.A. (2005). Towards safe, non-viral therapeutic gene expression in humans. Nat. Rev. Genet. 6, 299-310.
16. HACKER, H., MISCHAK, H., MIETHKE, T., LIPTAY, S., SCHMID, R., SPARWASSER, T., HEEG, K., LIPFORD, G.B., and WAGNER, H. (1998). CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J. 17, 6230-6240.
17. HARTMANN, G., and KRIEG, A.M. (2000). Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J. Immunol. 164, 944-953.
18. HEFENEIDER, S.H., BENNETT, R.M., PHAM, T.Q., CORNELL, K., MCCOY, S.L., and HEINRICH, M.C. (1990). Identification of a cell-surface DNA receptor and its association with systemic lupus erythematosus. J. Invest. Dermatol. 94, 79S-84S.
19. HEIKENWALDER, M., POLYMENIDOU, M., JUNT. T., SIGURDSON, C., WAGNER, H., AKIRA, S., ZlNKERNAGEL, R., and AGUZZI, A. (2004). Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration. Nat. Med. 10, 187-192.
20. HEIT, A., HUSTER, K.M., SCHMITZ, F., SCHIEMANN, M., BUSCH, D.H., and WAGNER, H. (2004). CpG-DNA aided cross-priming by cross-presenting B cells. J. Immunol. 172, 1501-1507.
21. HEMMI, H., TAKEUCHI, O., KAWAI, T., KAISHO, T., SATO, S., SANJO, H., MATSUMOTO, M., HOSHINO, K., WAGNER, H., TAKEDA, K., et al. (2000). A Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745.
22. HOCHREIN, H., SCHLATTER, B., O'KEEFFE, M., WAGNER, C., SCHMITZ, F., SCHIEMANN, M., BAUER, S., SUTER, M., and WAGNER, H. (2004). Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways. Proc. Natl. Acad. Sci. USA 101, 11416-11421.
23. HOEBE, K., JANSSEN, E.M., KIM, S.O., ALEXOPOULOU, L., FLAVELL, R.A., HAN, J., and BEUTLER, B. (2003). Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways. Nat. Immunol. 4, 1223-1229.
24. JANEWAY, C.J., and BOTTOMLY, K. (1994). Signals and signs for lymphocyte responses. Cell 76, 275-285.
25. KADOWAKI, N., HO, S., ANTONENKO, S., MALEFYT, R.W., KASTELEIN, R.A., BAZAN, F., and LIU, Y.J. (2001). Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194, 863-869.
26. KAISHO, T., TAKEUCHI, O., KAWAI, T., HOSHINO, K., and AKIRA, S. (2001). Endotoxin-induced maturation of MyD88-deficient dendritic cells. J. Immunol. 166, 5688-5694.
27. KLINMAN, D.M., CURRIE, D., GURSEL, I., and VERTHELYI, D. (2004). Use of CpG oligodeoxynucleotides as immune adjuvants. Immunol. Rev. 199, 201-216.
28. KRIEG, A.M., YI, A.K., MATSON, S., WALDSCHMIDT, T.J., BISHOP, G.A., TEASDALE, R., KORETZKY, G.A., and KLINMAN, D.M. (1995). CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546-549.
29. KRUG, A., TOWAROWSKI, A., BRITSCH, S., ROTHENFUSSER, S., HORNUNG, V., BALS, R., GIESE, T., ENGELMANN, H., ENDRES, S., KRIEG, A.M., et al. (2001). Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur. J. Immunol. 31, 3026-3037.
30. LANGLADE-DEMOYEN, P., GARCIA-PONS, F., CASTIGLIONI, P., GARCIA, Z., CARDINAUD, S., XIONG, S., GERLONI, M., and ZANETTI, M. (2003). Role of T cell help and endoplasmic reticulum targeting in protective CTL response against influenza virus. Eur. J. Immunol. 33, 720-728.
31. LEHMANN, M.J., and SCZAKIEL, G. (2005). Spontaneous uptake of biologically active recombinant DNA by mammalian cells via a selected DNA segment. Gene Ther. 12, 446-451.
32. LENERT, P., RASMUSSEN, W., ASHMAN, R.F., and BALLAS, Z.K. (2003). Structural characterization of the inhibitory DNA motif for the type A(D)CpG-induced cytokine secretion and NK-cell lytic activity in mouse spleen cells. DNA Cell Biol. 22, 621-631.
33. LEVY, M.Y., BARRON, L.G., MEYER, K.B., and SZOKA, F.C., JR. (1996). Characterization of plasmid DNA transfer into mouse skeletal muscle: Evaluation of uptake mechanism, expression and secretion of gene products into blood. Gene Ther. 3, 201-211.
34. LIANG, H., NISHIOKA, Y., REICH, C.F., PISETSKY, D.S., and LIPSKY, P.E. (1996). Activation of human B cells by phosphorothioatc oligodeoxynucleoticles. J. Clin. Invest. 98, 1119-1129.
35. LIU, M., ACRES, B., BALLOUL, J.M., BIZOUARNE, N., PAUL, S., SLOS, P., and SQUIBAN, P. (2004). Gene-based vaccines and immunotherapeutics. Proc. Natl. Acad. Sci. USA 101 (Suppl 2), 14567-14571.
36. MACFARLANE, D.E., and MANZEL, L. (1998). Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds. J. Immunol. 160, 1122-1131.
37. PERUSSIA, B., FANNING, V., and TRINCHIERI, G. (1985). A leukocyte subset bearing HLA-DR antigens is responsible for in vitro alpha interferon production in response to viruses. Nat. Immun. Cell Growth Regul. 4, 120-137.
38. POLTORAK, A., SMIRNOVA, I., CLISCH, R., and BEUTLER, B. (2000). Limits of a deletion spanning Tlr4 in C57BL/10ScCr mice. J. Endotoxin Res. 6, 51-56.
39. RAZ, E., CARSON, D.A., PARKER, S.E., PARR, T.B., ABAI, A.M., AICHINGER, G., GROMKOWSKI, S.H., SINGH, M., LEW, D., YANKAUCKAS, M.A., et al. (1994). Intradermal gene immunization: The possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Natl. Acad. Sci. USA 91, 9519-9523.
40. ROMAN, M., MARTIN, O.E., GOODMAN, J.S., NGUYEN, M.D., SATO, Y., RONAGHY, A., KORNBLUTH, R.S., RICHMAN, D.D., CARSON, D.A., and RAZ, E. (1997). Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat. Med. 3, 849-854.
41. RUTZ, M., METZGER. J., GELLERT, T., LUPPA, P., LIPFORD, G.B., WAGNER, H., and BAUER, S. (2004). Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner. Eur. J. Immunol. 34, 2541-2550.
42. SATO, T., SATO, N., TAKAHASHI, S., KOSHIBA. H., and KIKUCHI, K. (1986). Specific cytotoxicity of a long-term cultured T cell clone on autologous mammary cancer cells. Cancer Res. 46, 4384-4389.
43. SATO, Y., ROMAN, M., TIGHE, H., LEE, D., CORR, M., NGUYEN, M.D., SILVERMAN, G.J., LOTZ, M., CARSON, D.A., and RAZ, E. (1996). Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273, 352-354.
44. SPARWASSER, T., MIETHKE, T., LIPFORD, G., BORSCHERT, K., HACKER, H., HEEG, K., and WAGNER, H. (1997a). Bacterial DNA causes septic shock. Nature 386, 336-337.
45. SPARWASSER, T., MIETHKE, T., LIPFORD, G., ERDMANN, A., HACKER, H., HEEG, K., and WAGNER, H. (1997b). Macrophages sense pathogens via DNA motifs: Induction of tumor necrosis factor-alpha-mediated shock. Eur. J. Immunol. 27, 1671-1679.
46. SPARWASSER, T., KOCH, E.S., VABULAS, R.M., HEEG, K., LIPFORD, G.B., ELLWART, J.W., and WAGNER, H. (1998). Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur. J. Immunol. 28, 2045-2054.
47. SPIES, B., HOCHREIN, H., VABULAS, M., HUSTER, K., BUSCH, D.H., SCHMITZ, F., HEIT, A., and WAGNER, H. (2003). Vaccination with plasmid DNA activates dendritic cells via Toll-like receptor 9 (TLR9) but functions in TLR9-deficicnt mice. J. Immunol. 171, 5908-5912.
48. ULEVITCH, R.J. (2003). Regulation of receptor-dependent activation of the innate immune response. J. Infect. Dis. 187 (Suppl 2), S351-S355.
49. UNANUE, E.R. (2002). Perspective on antigen processing and presentation. Immunol. Rev. 185, 86-102.
50. XIONG, S., GERLONI, M., and ZANETTI, M. (1997). In vivo role of B lymphocytes in somatic transgcne immunization. Proc. Natl. Acad. Sci. USA 94, 6352-6357.
51. YASUDA, K., YU, P., KIRSCHNING, C.J., SCHLATTER, B., SCHMITZ, F., HEIT, A., BAUER, S., HOCHREIN, H., and WAGNER, H. (2005). Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dcpendent and -independent pathways. J. Immunol. 174, 6129-6136.
52. YOSHIDA, H., OKABE, Y., KAWANE, K., FUKUYAMA, H., and NAGATA, S. (2005). Lethal anemia caused by interferon-beta produced in mouse embryos carrying undigested DNA. Nat. Immunol 6, 49-56.
53. ZANETTI, M., CASTIGLIONI, P., SCHOENBERGER, S., and GERLONI, M. (2003). The role of relB in regulating the adaptive immune response. Ann. N. Y. Acad. Sci. 987, 249-257.
54. ZANETTI, M., CASTIGLIONI, P., RIZZI, M., WHEELER, M., and GERLONI, M. (2004). B lymphocytes as APC based genetic vaccines. Immunol. Rev. 199, 264-278.